ISRCTN ISRCTN38035929
DOI https://doi.org/10.1186/ISRCTN38035929
Protocol serial number N/A
Sponsor Neurological Institute of Colombia (Colombia)
Funder Neurological Institute of Colombia, Medellín (Colombia)
Submission date
16/02/2012
Registration date
27/02/2012
Last edited
08/12/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Visual impairment is a decreased ability to see to a degree that causes problems not fixable by usual means, such as glasses. There are about 180 million visually impaired people in the world. Visual impairment can be caused by defects in the eye or neurological problems in the nerves that carry information from the eye to the brain, where visual images are interpreted. The aim of this study is to test a new method of rehabilitation for low or poor vision.

Who can participate?
Patients with poor vision of neurological origin, aged over 18, living in Colombia, South America.

What does the study involve?
The study involves a new method of rehabilitation based on covering the healthy eye (i.e., the eye with better vision) and stimulating the eye with poor vision for periods of 5 hours daily for 10 days. The intensive stimulation is applied through a computer program and involves different kinds of stimuli, including discrimination of contrast and color, interpreting complex shapes, reading paragraphs with different font sizes, and perception of motion, speed and contour.

What are the possible benefits and risks of participating?
The potential benefit would be some degree of recovery of vision.

Where is the study run from?
Neurological Institute of Colombia.

When is the study starting and how long is it expected to run for?
June 2010 to June 2012.

Who is funding the study?
Neurological Institute of Colombia.

Who is the main contact?
José Iván Jiménez
direccion@neurologico.org.co

Contact information

Dr Jose Ivan Jimenez
Scientific

Neurological Institute of Colombia
Calle 55 No. 46-36
Medellin
-
Colombia

Phone +57 4 5718178
Email direccion@neurologico.org.co

Study information

Primary study designInterventional
Study designQuasi-experimental clinical trial with intervention
Secondary study designCohort study
Study type Participant information sheet
Scientific titleVisual rehabilitation: brain plasticity or neuronal regeneration?
Study objectivesA 78 years old man presented an ischemic optic neuropathy of the right eye, leaving him with a vision of 20/200; this low vision remain stable for 6 years when he repeated ischemic optic neuropathy in the left eye, also producing low vision in that eye; the right eye, the affected first, recovered a lo of the loss of vision in the course of 2 or 3 months.

Based on this observation we elaborate the hypothesis for this research which consists of a rehabilitation therapy based on the occlusion of the healthy eye or the eye with better vision for 5 hours daily for 2 weeks and submit the affected eye to an intensive optical functional occlusion therapy (OOF).
Ethics approval(s)Neurological Institute of Colombia Ethics Committee, 09/03/2009
Health condition(s) or problem(s) studiedLow vision
InterventionPatients who meet the criteria for inclusion and exclusion are intervened with occlusion of the normal or better eye and an intensive visual stimulation procedure for periods of 5 hours daily for 10 days. The intensive visual stimulation is applied through a computer program, with stimuli of different kinds, such as discrimination of contrast, color vision, interpretation of complex shapes, reading paragraphs with different font sizes, perception of motion, speed and contour etc. fMRI and visual evoked potentials are also performed. All this test are realized before and after intervention
Intervention typeOther
Primary outcome measure(s)

Comparison of tests before and after intervention will permit the evalution of the results

Key secondary outcome measure(s)

Changes in activation of cortical visual areas by functional magnetic resonance

Completion date30/06/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration30
Key inclusion criteria1. Age greater than or equal to 18
2. Isquemic optic neuropathy
3. Optic neuropathy by Multiple Sclerosis
4. Amblyopia secondary to strabismus
5. Traumatic optic neuropathy
6. At least one year of evolution of the previous conditions
7. Alteration of unilateral or bilateral visual acuity, defined as unilateral or bilateral visual acuity less than 20/60
8. In case of bilateral involvement, there should be an eye with better visual acuity, still below the 20/60
9. The visually impaired should have some stability over time, without clinical signs of improvement, even with the best possible optical correction or intervention
10. Clinical condition equivalent to a diagnosis of low vision
Key exclusion criteria1. Visual deficit bilaterally and in the same visual range
2. Optic Atrophy of nonspecific of uncertain origin
3. Optical refractive errors
4. Low vision of ophthalmic pathology: glaucoma, sequelae of retinopathy of prematurity, hypertensive retinopathy, diabetic retinopathy, cataract, retinitis pigmentosa and macular degeneration associated with age
5. Presence of tumor disease of the optic nerve
6. Intensive therapy with steroids in the last 6 months
7. Relapsed Acute optic neuritis type in the last 6 months
8. Lack of ability to understand instructions and adhere to intervention
Date of first enrolment30/06/2010
Date of final enrolment30/06/2012

Locations

Countries of recruitment

  • Colombia

Study participating centre

Neurological Institute of Colombia
Medellin
-
Colombia

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes